Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 6/20 | 0.50 |
| ▸ | HTR2A | P28223 | 2/20 | 0.48 |
| ▸ | HTR2B | P41595 | 1/20 | 0.44 |
| ▸ | PDE4B | Q07343 | 13/20 | 0.43 |
| ▸ | PDE4A | P27815 | 9/20 | 0.43 |
| ▸ | PDE4C | Q08493 | 9/20 | 0.43 |
| ▸ | PDE4D | Q08499 | 9/20 | 0.43 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7693887 | 0.99 | HTR2C (0.49) | HTR2CHTR2AHTR2BPDE4BPDE4A | |
| SCHEMBL7692634 | 0.93 | PDE4B (0.45) | HTR2CHTR2AHTR2BPDE4BPDE4A | |
| SCHEMBL8707745 | 0.90 | HTR2C (0.49) | HTR2CHTR2AHTR2BPDE4BPDE4A | |
| SCHEMBL8708720 | 0.90 | HTR2C (0.50) | HTR2CHTR2AHTR2BPDE4BPDE4A | |
| SCHEMBL8710723 | 0.89 | HTR2C (0.47) | HTR2CHTR2AHTR2BPDE4BPDE4A | |
| SCHEMBL7695513 | 0.89 | HTR2C (0.49) | HTR2CHTR2AHTR2BPDE4BPDE4A | |
| SCHEMBL8708038 | 0.88 | HTR2C (0.53) | HTR2CHTR2AHTR2BMCHR1 | |
| SCHEMBL8710736 | 0.88 | HTR2C (0.47) | HTR2CHTR2AHTR2BPDE4BMCHR1 | |
| SCHEMBL7700899 | 0.87 | PDE4B (0.47) | HTR2CHTR2AHTR2BPDE4BPDE4A | |
| SCHEMBL8707714 | 0.87 | PDE4B (0.42) | PDE4BPDE4APDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1998042666-A1 | NOVEL 3,4-DIALKOXYPHENYL DERIVATIVES AND THE USE THEREOF | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 1998-10-01 | — | — | WO | disclosed |